Search the Newsreel

Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Sanara MedTech Inc. (SMTI) to MiMedx Group, Inc. (MDXG). KSF is examining whether the offered consideration of $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share undervalues the …

Earnings To Watch: USANA (USNA) Reports Q2 Results Tomorrow

USANA Health Sciences (USNA) is set to report its Q2 earnings this Tuesday. The market expects flat year-on-year revenue, a slowdown from last year's 10.8% increase, despite analysts reconfirming estimates. The company has a history of missing Wall Street's revenue estimates multiple times over …

Sanara MedTech (NASDAQ:SMTI) Downgraded by Wall Street Zen to Buy

USANA Health Sciences, Inc. Revenue Breakdown – NYSE:USNA

USANA Health Sciences, Inc. (NYSE: USNA) reported total revenue of $925.26 million USD last year. The Core Nutritional segment was the top performer, generating $775.45 million USD, while China was the largest regional contributor with $381.82 million USD in revenue.

Sanara MedTech Inc. (SMTI) filer’s amended 13G shows exit from share ownership

An amended Schedule 13G filing for Sanara MedTech Inc. (SMTI) indicates that investment advisor Christopher M. Plahm, along with Tall Pines Capital, LLC, and Stonebridge Wealth Management, LLC, no longer beneficially own shares in the company. The filing reports 0 shares owned, representing 0.0% …

New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow

USANA Health Sciences announced the results of a 12-week consumer study for its skincare supplement, Glow, showing significant improvements in participants' skin. The study, involving 36 individuals in the U.S. and Mexico, reported high percentages of brighter-looking, more radiant, and even-toned skin, along with …

SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36

H.C. Wainwright has downgraded SANARA MEDTECH INC (SMTI.O) from a "Buy" rating to "Neutral" and simultaneously lowered its target price to $35 from $36. This change in rating and price target reflects the analyst's updated view on the company's prospects. The article reiterates this …

Glow-Promoting Cellular Nutrition Formulas

USANA Health Sciences has introduced Glow, a cellular nutrition supplement designed to promote healthy, radiant skin. A 12-week consumer trial involving 36 participants showed that over 97% experienced improvements in brightness and skin tone, with significant gains in hydration, firmness, and elasticity. The product's …

Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)?

Sanara MedTech Inc. (SMTI) has seen a significant share price rise and its stock is currently undervalued according to Simply Wall St's valuation model, trading below its intrinsic value of $44.08. The company's earnings are expected to double in the coming years, indicating a …

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders

Ademi LLP is investigating Sanara MedTech Inc. (Nasdaq: SMTI) regarding its transaction with MiMedx, examining whether public shareholders are receiving a fair price and if the Sanara board fulfilled its fiduciary duties. The investigation focuses on the $35 per share cash-and-stock deal, insider benefits, …

Sanara MedTech to Be Acquired by MiMedx in $35-Per-Share Cash-and-Stock Merger

Sanara MedTech is set to be acquired by MiMedx in a cash-and-stock merger, valuing Sanara at approximately $35 per share. The deal aims to combine two wound-care businesses and is supported by a concurrent voting agreement from holders of about 38.9% of Sanara's voting …

SARAY MATBAACILIK - KAP Haberleri - 2026-07-30 tarihli

MiMedx Group (SMTI) details Sanara MedTech buyout and 2027 profit goals

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Sana Biotechnology, Inc. (NASDAQ: SANA) breached their fiduciary duties to shareholders. The firm encourages long-term Sana shareholders to contact them to discuss legal options, including seeking corporate governance reforms …

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the proposed sale of Sanara MedTech Inc. (SMTI) to MiMedx Group, Inc. and is encouraging Sanara shareholders to examine their rights and options. The investigation focuses on whether Sanara's board failed to secure the …

MiMedx Group Q2 Earnings Call Highlights

Key Points Interested in MiMedx Group, Inc? Here are five stocks we like better. MiMedx agreed to acquire Sanara MedTech for $35 per share, adding more than $100 million in surgical revenue and approximately $4 billion in addressable market opportunity. The combined company expects …

MiMedx plans Sanara MedTech (SMTI) acquisition and prepares S-4 filing

MiMedx has announced its intention to acquire Sanara MedTech, aiming to create a larger regenerative medicine platform with a broader product portfolio for wound care and surgical applications. The acquisition is expected to close by year-end, pending customary closing conditions and regulatory approval. MiMedx …

MIMEDX to acquire Sanara MedTech for $350 million

MiMedx Group Inc. announced its definitive merger agreement to acquire Sanara MedTech Inc. for approximately $350 million. Sanara shareholders will receive $33.00 in cash and 0.4735 shares of MIMEDX common stock per share, representing a 46% premium to Sanara's 30-day volume-weighted average share price. …

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- …

USANA Health Sciences Number of Employees 2026 | Employee Count & Headcount Data

USANA Health Sciences (USNA) had 1,580 employees worldwide as of March 2026, marking a 4.6% decline from 2023. The company's workforce is primarily concentrated in the United States, Philippines, and Canada, with Mexico being its fastest-growing location. USANA is actively hiring, though job postings …

MiMedx agrees to buy Sanara MedTech for $35 a share (SMTI:NASDAQ)

MiMedx has announced an agreement to acquire Sanara MedTech for $35 per share. The deal will provide Sanara shareholders with $33.00 in cash and 0.4735 shares of MiMedx common stock for each share they own. This acquisition represents a significant merger in the medical …

USANA Health Sciences Inc (USNA) Financial Health: Profitability & Balance Sheet Analysis

USANA Health Sciences Inc (USNA) currently boasts a robust financial score of 8.24, ranking 12th in the Food & Tobacco industry. The company reported a quarterly revenue of $250.22 million, showing a 0.27% year-over-year increase, and a significant 20.07% year-over-year increase in net profit. …

Does Asana’s (ASAN) Accounting Exit Undercut Or Underscore Its Upbeat Growth Narrative?

(ASAN) and the Role of Price-Sensitive Allocations

This article provides an AI-driven analysis of Asana Inc. Class A (NASDAQ: ASAN), highlighting weak near-term sentiment with a potential for long-term weakness resumption. It identifies a breakout underway, suggesting potential for higher levels due to a lack of resistance above the current price. …

Artisanal Spirits Company PLC Revenue Breakdown – LSE:ART

How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing

This article analyzes Usana Health Sciences Inc. (USNA) using AI models to determine its effect on rotational strategy timing. It identifies near-term weak sentiment, no clear price positioning, and offers institutional trading strategies including long, momentum breakout, and short positions. The analysis also provides …

BESLER GIDA VE K - KAP Haberleri - 2026-07-28 tarihli

USANA Health Sciences (USNA) to Announce Earnings on Tuesday

USANA Health Sciences (NYSE:USNA) is scheduled to announce its Q2 2026 earnings on Tuesday, August 4th, with analysts expecting $0.43 EPS on $235.0 million in revenue. This follows a strong previous quarter where the company surpassed estimates with $0.61 EPS and $250.22 million in …

USANA Health Sciences CIO Benedict Peter Increases Stock Holdings via RSU Vesting and Market Sale

USANA Health Sciences CIO Benedict Peter increased his stock holdings on July 25, 2026, through a combination of restricted stock unit vesting and open market transactions. This move, disclosed on July 27, 2026, demonstrates executive confidence in the nutritional supplement and wellness company (NYSE: …

Sana Biotechnology Inc (SANA) Cash Flow

This article provides a detailed cash flow statement for Sana Biotechnology Inc (SANA), including quarterly and annual data for operating, investing, and financing activities. It presents key financial metrics such as net income, capital expenditures, and free cash flow, alongside year-over-year percentage changes. The …

USANA Health Sciences Inc (USNA) Cash Flow

This article provides a detailed historical cash flow statement for USANA Health Sciences Inc (USNA), offering both quarterly and annual data for operating, investing, and financing activities through FY2026Q1. It also includes definitions and explanations of key cash flow metrics like operating cash flow, …

SANA|Sana Biotechnology Inc|Price:3.285|Chg%:+0.105

This article provides a detailed financial overview of Sana Biotechnology Inc (SANA), including its stock price, market cap, and key financial indicators. It presents current and historical data for income statements, balance sheets, and cash flow statements, along with recent earnings reports and analyst …

Sanara MedTech Inc. Revenue Breakdown – NASDAQ:SMTI

Sanara MedTech Inc. (NASDAQ:SMTI) generated $103.12 million in revenue last year, with its Soft Tissue Repair Products segment contributing the most at $91.35 million. The United States was the primary geographic contributor, accounting for the entire $103.12 million in revenue, an increase from $86.67 …

BlackRock (ASAN) discloses 5.3% beneficial ownership stake in Asana Class A stock

BlackRock, Inc. has disclosed a 5.3% beneficial ownership stake in Asana, Inc.'s Class A stock, as reported in a Schedule 13G filing. As of June 30, 2026, BlackRock beneficially owns 8,596,106 Class A shares, with sole voting power over 8,448,070 shares and sole dispositive …

Form 4 USANA Health Sciences Inc For: 27 July By Investing.com

This article reports on a Form 4 filing for USANA Health Sciences Inc. on July 27. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of …

USANA Health Sciences Director Nixon J. Scott Acquires 1,632 Restricted Stock Units, Signaling Confidence

USANA Health Sciences Director Nixon J. Scott recently acquired 1,632 restricted stock units on July 23, 2026. This transaction is seen as a potential signal of confidence in the company's future performance and governance. The acquisition has drawn investor interest, prompting speculation on its …